| Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders AC Rawstron, A Orfao, M Beksac, L Bezdickova, R Brooimans, H Bumbea, ... haematologica 93 (3), 431-438, 2008 | 655 | 2008 |
| Generation of EPR-detectable nitrosyl-iron complexes in tumor target cells cocultured with activated macrophages. JC Drapier, C Pellat, Y Henry J Biol Chem 266, 10162-10167, 1991 | 361 | 1991 |
| The phenotype of normal, reactive and malignant plasma cells. Identification of" many and multiple myelomas" and of new targets for myeloma therapy R Bataille, G Jégo, N Robillard, S Barillé-Nion, JL Harousseau, P Moreau, ... Haematologica 91 (9), 1234-1240, 2006 | 349 | 2006 |
| The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t (11; 14) multiple myeloma C Touzeau, C Dousset, S Le Gouill, D Sampath, JD Leverson, AJ Souers, ... Leukemia 28 (1), 210-212, 2014 | 296 | 2014 |
| Interleukin-6 is a growth factor for nonmalignant human plasmablasts G Jego, R Bataille, C Pellat-Deceunynck Blood, The Journal of the American Society of Hematology 97 (6), 1817-1822, 2001 | 270 | 2001 |
| Nitric oxide, a biological effector: electron paramagnetic resonance dectection of nitrosyl-iron-protein complexes in whole cells Y Henry, C Ducrocq, JC Drapier, D Servent, C Pellat, A Guissani Eur Biophys J 20, 1-15, 1991 | 260 | 1991 |
| The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma. C Pellat-Deceunynck, S Barille, G Jego, D Puthier, N Robillard, D Pineau, ... Leukemia (08876924) 12 (12), 1998 | 256 | 1998 |
| Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells C Pellat-Deceunynck, R Bataille, N Robillard, JL Harousseau, MJ Rapp, ... | 256 | 1994 |
| Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors G Jego, R Bataille, A Geffroy-Luseau, G Descamps, C Pellat-Deceunynck Leukemia 20 (6), 1130, 2006 | 240 | 2006 |
| Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells G Jego, N Robillard, D Puthier, M Amiot, F Accard, D Pineau, ... Blood, The Journal of the American Society of Hematology 94 (2), 701-712, 1999 | 235 | 1999 |
| IFN-g-activated macrophages: detection by electron paramagnetic resonance of complexes between L-arginine-derived nitric oxide and non-heme iron proteins C Pellat, Y Henry, JC Drapier Biochem Biophys Res Commun 166, 119-125, 1990 | 224 | 1990 |
| Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization C Pellat-Deceunynck, S Barillé, D Puthier, MJ Rapp, JL Harousseau, ... Cancer Research 55 (16), 3647-3653, 1995 | 189 | 1995 |
| A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines J Moreaux, B Klein, R Bataille, G Descamps, S Maïga, D Hose, ... Haematologica 96 (4), 574, 2011 | 179 | 2011 |
| Toll-like receptors: lessons to learn from normal and malignant human B cells D Chiron, I Bekeredjian-Ding, C Pellat-Deceunynck, R Bataille, G Jego Blood, The Journal of the American Society of Hematology 112 (6), 2205-2213, 2008 | 161 | 2008 |
| PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance B Tessoulin, G Descamps, P Moreau, S Maïga, L Lodé, C Godon, ... Blood, The Journal of the American Society of Hematology 124 (10), 1626-1636, 2014 | 160 | 2014 |
| The cancer germ‐line genes MAGE‐1, MAGE‐3 and PRAME are commonly expressed by human myeloma cells C Pellat‐Deceunynck, MP Mellerin, N Labarrière, G Jego, ... European journal of immunology 30 (3), 803-809, 2000 | 160 | 2000 |
| CD28, a marker associated with tumoral expansion in multiple myeloma. N Robillard, G Jego, C Pellat-Deceunynck, D Pineau, D Puthier, ... Clinical cancer research: an official journal of the American Association …, 1998 | 148 | 1998 |
| ABT-737 is highly effective against molecular subgroups of multiple myeloma L Bodet, P Gomez-Bougie, C Touzeau, C Dousset, G Descamps, S Maïga, ... Blood, The Journal of the American Society of Hematology 118 (14), 3901-3910, 2011 | 123 | 2011 |
| Noxa controls Mule-dependent Mcl-1 ubiquitination through the regulation of the Mcl-1/USP9X interaction P Gomez-Bougie, E Ménoret, P Juin, C Dousset, C Pellat-Deceunynck, ... Biochemical and biophysical research communications 413 (3), 460-464, 2011 | 115 | 2011 |
| Normal and malignant human plasma cells: proliferation, differentiation, and expansions in relation to CD45 expression C Pellat-Deceunynck, R Bataille Blood Cells, Molecules, and Diseases 32 (2), 293-301, 2004 | 115 | 2004 |
